Conduit Pharmaceuticals Inc (NASDAQ: CDT) flaunted slowness of -1.37% at $0.09, before settling in for the price of $0.10 at the close. Taking a more long-term approach, CDT posted a 52-week range of $0.08-$7.83.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. This publicly-traded company’s shares outstanding now amounts to $73.83 million, simultaneously with a float of $54.16 million. The organization now has a market capitalization sitting at $9.46 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1136, while the 200-day Moving Average is $1.5626.
Conduit Pharmaceuticals Inc (CDT) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Conduit Pharmaceuticals Inc industry. Conduit Pharmaceuticals Inc’s current insider ownership accounts for 46.26%, in contrast to 3.21% institutional ownership. According to the most recent insider trade that took place on Oct 03 ’24, this organization’s 10% Owner sold 1,500,000 shares at the rate of 0.10, making the entire transaction reach 156,450 in total value, affecting insider ownership by 8,400,000. Preceding that transaction, on Oct 04 ’24, Company’s 10% Owner sold 1,368,991 for 0.10, making the whole transaction’s value amount to 140,458. This particular insider is now the holder of 7,031,009 in total.
Conduit Pharmaceuticals Inc (NASDAQ: CDT) Trading Performance Indicators
Let’s observe the current performance indicators for Conduit Pharmaceuticals Inc (CDT). It’s Quick Ratio in the last reported quarter now stands at 0.56. The Stock has managed to achieve an average true range (ATR) of 0.01.
In the same vein, CDT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.14.
Technical Analysis of Conduit Pharmaceuticals Inc (CDT)
Now, what If we examine the latest scores posted by [Conduit Pharmaceuticals Inc, CDT]. During the last 5-days, its volume was lower the volume of 6.93 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 41.93% While, its Average True Range was 0.0138.
Raw Stochastic average of Conduit Pharmaceuticals Inc (CDT) in the period of the previous 100 days is set at 1.10%, which indicates a major fall in contrast to 38.36% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 111.39% that was lower than 134.94% volatility it exhibited in the past 100-days period.
